SRPT
Sarepta Therapeutics Inc
Price:  
123.88 
USD
Volume:  
851,351.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SRPT WACC - Weighted Average Cost of Capital

The WACC of Sarepta Therapeutics Inc (SRPT) is 8.0%.

The Cost of Equity of Sarepta Therapeutics Inc (SRPT) is 8.40%.
The Cost of Debt of Sarepta Therapeutics Inc (SRPT) is 5.50%.

Range Selected
Cost of equity 7.20% - 9.60% 8.40%
Tax rate 0.20% - 0.90% 0.55%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.8% - 9.3% 8.0%
WACC

SRPT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.71 0.84
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.20% 9.60%
Tax rate 0.20% 0.90%
Debt/Equity ratio 0.13 0.13
Cost of debt 4.00% 7.00%
After-tax WACC 6.8% 9.3%
Selected WACC 8.0%